CLEVELAND (Legal Newsline) - The judge overseeing multidistrict litigation against opioid manufacturers and distributors has named the teams of lawyers who will try to negotiate a settlement of hundreds of federal lawsuits - a complex task given parallel investigations and litigation by state attorneys general and potentially conflicting goals of private attorneys and their government counterparts.
Jury declares Abbvie's Androgel didn't cause man's lung clots, Abbvie didn't falsely market medication
After split verdicts in two prior trials over alleged harmful side effects and alleged misleading marketing of its testosterone replacement drug led to questionable verdicts worth more than $140 million each, drugmaker Abbvie has scored a clean win in the latest jury review of a plaintiff’s claims over the promotion and health impacts of Androgel.
Despite efforts by the Trump administration to pull the reins on many of the recent priorities at the Equal Employment Opportunity Commission, and amid a string of litigation losses, the federal anti-discrimination agency is holding course in pressing its years-long case against Dollar General. But what exactly that signals remains to be seen, according to employment attorney Rod Fliegel, who co-chairs the privacy and background checks practice at the firm of Littler Mendelson.
Cook County jumps into legal fray vs pharmaceutical makers, hires Simmons, Meyers & Flowers to sue over 'opioids'
Cook County, the second largest county in the U.S., has added its name to the ever-growing list of local governments demanding the makers of some of the most prescribed opioid painkillers pay out, saying the companies owe big money for costs the county has incurred in treating painkiller addiction and dealing with its aftermath at the county’s hospitals and other institutions.
While their competitor AbbVie seeks to undo jury verdicts worth nearly $290 million over testosterone replacement therapy drugs, drugmaker Auxilium has received a clean bill from a jury in its first court test over claims it and other similar drugmakers should be made to pay for alleged misleading marketing that led men to take the drugs, and suffered heart attacks as a result.
After two federal juries delivered $140 million verdicts against AbbVie, competing drugmaker Auxilium will be headed to trial over claims its testosterone replacement therapy drug Testim caused heart attacks in men who took the drug to treat “off-label” conditions, spurred by what plaintiffs alleged was misleading marketing from drugmakers.
For now, a Chicago federal judge has permitted a onetime student's suit to proceed against the University of Chicago, saying, while the student must furnish a more full explanation, he has squeaked out a plausible case a school official encouraged retaliation against him for complaining about sexual assault allegations.